# A Study for Tyrosine Kinase Inhibitors Discontinuation

> **NCT02897245** · — · UNKNOWN · sponsor: **Versailles Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Leukemia

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT02897245
- **Lead sponsor:** Versailles Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-12
- **Primary completion:** 2020-12
- **Final completion:** 2022-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2018-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02897245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02897245, "A Study for Tyrosine Kinase Inhibitors Discontinuation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02897245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*